Evidence map›Paper›PMID 30769858›Full record

ArticleCancers2019

Outpatient Cancer Care Delivery in the Context of E-Oncology: A French Perspective on "Cancer outside the Hospital Walls".

François Bertucci, Anne-Gaëlle Le Corroller-Soriano, Audrey Monneur-Miramon, Jean-François Moulin, Sylvain Fluzin, Dominique Maraninchi, Anthony Gonçalves

Abstract readLetter
In one paragraph

Article in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. The Evolving Role of Haematology Nursing Practice: A Cross-Sectional Survey.Mediterranean journal of hematology and infectious diseases · 2023
    Article
  5. "You really need a whole community": a qualitative study of mothers' need for and experiences with childcare support during cancer treatment and recovery.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Article
  6. Review
  7. Article
  8. Article
  9. Prostate cancer follow-up costs in Germany from 2000 to 2015.Journal of cancer survivorship : research and practice · 2022
    Article
  10. Testicular cancer follow-up costs in Germany from 2000 to 2015.Journal of cancer research and clinical oncology · 2021
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

François BertucciAix-Marseille Univ, INSERM U1068, CNRS UMR7258, Département d'Oncologie Médicale, Institut Paoli-Calmettes, CRCM, 13009 Marseille, France. bertuccif@ipc.unicancer.fr.
Anne-Gaëlle Le Corroller-SorianoAix-Marseille Univ, INSERM, IRD, SESSTIM, 13009 Marseille, France. anne-gaelle.le-corroller@inserm.fr.
Audrey Monneur-MiramonAix-Marseille Univ, INSERM U1068, CNRS UMR7258, Département d'Oncologie Médicale, Institut Paoli-Calmettes, CRCM, 13009 Marseille, France. monneura@ipc.unicancer.fr.
Jean-François MoulinAix-Marseille Univ, INSERM U1068, CNRS UMR7258, Département d'Oncologie Médicale, Institut Paoli-Calmettes, CRCM, 13009 Marseille, France. Moulinjf@ipc.unicancer.fr.
Sylvain FluzinDirection du Système d'Information et de l'Organisation, Institut Paoli-Calmettes, 13009 Marseille, France. Fluzins@ipc.unicancer.fr.
Dominique MaraninchiAix-Marseille Univ, INSERM U1068, CNRS UMR7258, Département d'Oncologie Médicale, Institut Paoli-Calmettes, CRCM, 13009 Marseille, France. maraninchid@ipc.unicancer.fr.
Anthony GonçalvesAix-Marseille Univ, INSERM U1068, CNRS UMR7258, Département d'Oncologie Médicale, Institut Paoli-Calmettes, CRCM, 13009 Marseille, France. goncalvesa@ipc.unicancer.fr.ORCID 0000-0001-7570-7439

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In oncology, the treatment of patients outside of hospitals has become imperative due to an increasing number of patients who are older and live longer, along with issues such as medical desertification, oncologist hyperspecialization, and difficulties in financing mounting health expenditures. Treatments have become less "invasive", with greater precision and efficiency. Patients can therefore receive most of their care outside of hospitals. The development of e-health can address these new imperatives. In this letter, we describe the different e-health tools and their potential clinical impacts in oncology, as already reported at every level of care, including education, prevention, diagnosis, treatment, and monitoring. A few randomized studies have yet demonstrated the clinical benefit. We also comment on issues and limits of "cancer outside the hospital walls" from the point of view of patients, health care professionals, health facilities, and public authorities. Care providers in hospitals and communities will have to adapt to these changes within well-coordinated networks in order to better meet patient expectations regarding increasing education and personalizing management. Ultimately, controlled studies should aim to definitively demonstrate areas of interest, benefits, and incentives, for not only patients, but also caregivers (formal and informal) and health care providers, health care facilities, and the nation.

Indexed as

cancerdigitale-healthoutpatienttelemedicine

Identifiers

PMID30769858
PMCPMC6406853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.